Drug executives seeking approval for female libido pill previously ran afoul of FDA rulesMarketing push made misleading, unsupported statements about the benefits of testosterone therapy while downplaying risks. What your patients are reading – Week of August 17, 2015 Press Review – August 14, 2015 Researchers use synchrotron to shed a lot of light on breast cancer What your patients are reading – Week of August 10, 2015 What your patients are reading – Week of August 4, 2015 Obstetrics ward reopening a vision of hope for Slave Lake Abortion pill RU 486 approved by Health Canada after lengthy review Approval comes a quarter century after women in France were first given access to it. Aromatase inhibitors superior to tamoxifen in reducing breast cancer mortality Five years of therapy reduces 10-year mortality by about 15% compared with tamoxifen. CFI awards funding to five York University projects First Previous 143 144 145 146 147 Next Last
